Rigaku to Acquire Agilent's X-Ray Diffraction Business.
M2 EQUITYBITES-March 31, 2015-Rigaku to Acquire Agilent's X-Ray Diffraction Business
(C)2015 M2 COMMUNICATIONS http://www.m2.com
31 March 2015 - Japanese life sciences instrument maker Rigaku Corp. has agreed to buy US-based life sciences company Agilent Technologies Inc.'s (NYSE: A) X-ray diffraction business, the companies aid.
Formerly known as Oxford Diffraction within Varian when that company was acquired by Agilent in 2010, the XRD group is a manufacturer of single-crystal X-ray instruments for the global chemical crystallography market.
Rigaku said it plans to combine XRD with its existing crystallography business to form a new business unit. XRD products will continue to be developed and produced at existing factories in Poland and Japan.
The transaction is expected to be final May 1, 2015, subject to local laws and customary closing conditions.
No financial terms were disclosed.
Rigaku was launched in Japan in 1951. The company provides analytical and industrial instrumentation technology. Rigaku and its subsidiaries form a global group focused on general-purpose analytical instrumentation and the life sciences.
The company is engaged in X-ray spectrometry, X-ray diffraction, non-destructive testing, X-ray microscopy, Raman spectroscopy and optics, as well as small molecule and protein crystallography and semiconductor metrology.
Rigaku employs over 1,100 people in the manufacturing, sales and support of its analytical equipment, which is used in more than 70 countries around the world for research, development, and quality assurance activities.
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Publication:||M2 EquityBites (EQB)|
|Date:||Mar 31, 2015|
|Previous Article:||Silvercrest Asset Management to Buy New Jersey Investment Adviser for USD 12m.|
|Next Article:||GTCR Sells Banking Software, Payments Firm Fundtech for USD 1.25bn.|